The long term objective of this study is to understand the genetic factors controlling the development and function of the serotonergic system in the human brain. The proposed experiments will test the hypothesis that there is a conserved genetic program controlling the human and the mouse serotonin (5-HT) system, specifically focusing on the transcription factor Pet-1. Molecular cloning, transgenic mouse production, histology, reverse transcriptase Real-Time PCR, high performance liquid chromatography, and behavioral testing will be the methods used in the three proposed specific aims. The organization of the human Bacterial Artificial Chromosome (BAC) containing Fev, the human Pet-1 homologue, will be determined and then the BAC will be used to generate transgenic mouse lines. The transgene (TG) positive, Pet-1 null mice will be examined to determine hPet-1's functionality in the mouse 5-HT system, specifically looking at 5-HT levels in the brain, and at the expression of tryptophan hydroxylase (the enzyme that synthesizes 5-HT) and the serotonin transporter (SERT). The anxiety and aggression levels of the TG+ mice will be evaluated using behavioral assays such as the open field test, elevated plus maze, and the resident intruder assay.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Predoctoral Individual National Research Service Award (F31)
Project #
5F31MH073296-02
Application #
6955877
Study Section
Special Emphasis Panel (ZRG1-F03A (20))
Program Officer
Curvey, Mary F
Project Start
2004-09-30
Project End
2006-09-29
Budget Start
2005-09-30
Budget End
2006-09-29
Support Year
2
Fiscal Year
2005
Total Cost
$26,522
Indirect Cost
Name
Case Western Reserve University
Department
Neurosciences
Type
Schools of Medicine
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Lerch-Haner, Jessica K; Frierson, Dargan; Crawford, LaTasha K et al. (2008) Serotonergic transcriptional programming determines maternal behavior and offspring survival. Nat Neurosci 11:1001-3